Novo Nordisk A/S (NOVO-B)の価格はいくらですか

Novo Nordisk A/S (NOVO-B)の価格は$43.92です

Novo Nordisk A/S (NOVO-B)の時価総額は何ですか

Novo Nordisk A/S (NOVO-B)の時価総額は$195.10Bです

Novo Nordisk A/S（NOVO-B）の株価履歴

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

年	パフォーマンス
2026 (TTM)	-3.05%
2025	-51.49%
2024	1.66%
2023	53.39%
2022	17.33%
2021	57.90%
2020	22.88%
2019	26.30%
2018	-13.92%
2017	49.76%
2016	-37.96%
2015	26.26%
2014	24.70%
2013	10.83%
2012	43.56%
2011	6.06%
2010	0.00%

年

パフォーマンス

2026 (TTM)

-3.05%

2025

-51.49%

2024

1.66%

2023

53.39%

2022

17.33%

2021

57.90%

2020

22.88%

2019

26.30%

2018

-13.92%

2017

49.76%

2016

-37.96%

2015

26.26%

2014

24.70%

2013

10.83%

2012

43.56%

2011

6.06%

2010

0.00%

企業	株価	変化率 1年%	国
Eli Lilly and Company LLY.US	$1.11K	47.49%	US
Johnson & Johnson JNJ.US	$265.87	49.31%	US
AbbVie Inc. ABBV.US	$257.01	17.71%	US
Roche Holding AG RO.SW	$459.10	30.72%	CH
Merck & Co., Inc. MRK.US	$144.05	73.95%	US

企業

株価

変化率 1年%

国